JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB263333

Human RPS27L knockout HeLa cell lysate

Be the first to review this product! Submit a review

|

(0 Publication)

RPS27L KO cell lysate available now. KO validated. Free of charge wild type control included. Knockout achieved by using CRISPR/Cas9, 5 bp deletion in exon2 and 7 bp deletion in exon2.
2 Images
Sanger Sequencing - Human RPS27L knockout HeLa cell lysate (AB263333)
  • Sanger seq

Unknown

Sanger Sequencing - Human RPS27L knockout HeLa cell lysate (AB263333)

Allele-1 : 7 bp deletion in exon2

Sanger Sequencing - Human RPS27L knockout HeLa cell lysate (AB263333)
  • Sanger seq

Unknown

Sanger Sequencing - Human RPS27L knockout HeLa cell lysate (AB263333)

Allele-2 : 5 bp deletion in exon2

Key facts

Cell type

HeLa

Species or organism

Human

Tissue

Cervix

Knockout validation

Sanger Sequencing

Mutation description

Knockout achieved by using CRISPR/Cas9, 5 bp deletion in exon2 and 7 bp deletion in exon2.

Disease

Adenocarcinoma

Product details

Knockout cell lysate achieved by CRISPR/Cas9.

REACH authorisation
Abcam has not and does not intend to apply for the REACH Authorisation of customers' uses of products that contain European Authorisation list (Annex XIV) substances.
It is the responsibility of our customers to check the necessity of application of REACH Authorisation, and any other relevant authorisations, for their intended uses.

Lysate preparation: Our lysates are made using RIPA buffer to which we add a protease inhibitor cocktail and phosphatase inhibitor cocktail (ratio: 300:100:10). This means that the protein of interest is denatured. If you require a native form of the protein please use the live cell version. Please refer to our lysis protocol for further details on how our lysates are prepared.

User storage instructions: Lyophilizate may be stored at 4°C. After reconstitution, store at -20°C for short-term storage or -80°C for long-term storage.

This product is subject to limited use licenses from The Broad Institute and ERS Genomics Limited, and is developed with patented technology. For full details of the limited use licenses and relevant patents please refer to our limited use license and patent pages.

What's included?

{ "values": { "1Kit": { "sellingSize": "1 Kit", "publicAssetCode":"ab263333-1Kit", "assetComponentDetails": [ { "size":"1 x 100 µg", "name":"Human RPS27L knockout HeLa cell lysate", "number":"AB263333-CMP01", "productcode":"" }, { "size":"1 x 100 µg", "name":"Human wild-type HeLa cell lysate", "number":"AB263333-CMP02", "productcode":"" } ] } } }

Properties and storage information

Gene name
RPS27L
Gene editing type
Knockout
Gene editing method
CRISPR technology
Knockout validation
Sanger Sequencing
Shipped at conditions
Ambient - Can Ship with Ice
Appropriate short-term storage conditions
-20°C
Appropriate long-term storage conditions
-20°C

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

RPS27L also known as Ribosomal Protein S27-like or Metallopanstimulin-1 (MPS-1) is a component of the ribosome with a molecular weight of approximately 9.5 kDa. It is expressed across various tissues particularly in liver and prostate. Mechanically RPS27L functions as part of the ribosomal machinery where it plays a role in the assembly and stability of ribosomal constituents necessary for protein synthesis.
Biological function summary

This protein contributes to the regulation of the cellular response to DNA damage and is involved in the control of cell cycle progression. It is part of the small subunit of the ribosome where it associates with other ribosomal proteins to form a functional ribosomal unit. Its activity emphasizes its importance in maintaining genomic stability and proper cellular functions.

Pathways

RPS27L plays a substantial role in the DNA damage response and the p53 signaling pathway. It interacts with the p53 protein an important tumor suppressor regulating p53 levels and activity following genotoxic stress. The interplay between RPS27L and p53 emphasizes its involvement in pathways that oversee damage repair mechanisms particularly by influencing p53-mediated transcriptional regulation and apoptosis.

RPS27L has notable associations with cancer and ribosomopathies. Aberrant function or expression of RPS27L can contribute to tumorigenesis often through its interplay with the p53 pathway. Additionally it connects with proteins such as MDM2 a critical regulator of p53 in the context of oncogenic disorders highlighting its potential as a therapeutic target in related malignancies.

Quality control

STR analysis

CSF1PO, D13S317, D7S820, D5S818, TH01, D16S539, TPOX

Cell culture

Biosafety level

EU: 2 US: 2

Adherent/suspension

Adherent

Gender

Female

Product protocols

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com